Enanta Pharmaceuticals, Inc.

ENTA · NASDAQ
Analyze with AI
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Assets
Cash & Equivalents$32,298$37,233$85,388$43,994
Short-Term Investments$156,566$210,953$284,522$205,238
Receivables$6,882$38,645$39,618$49,036
Inventory$0$0$0$0
Other Curr. Assets$8,590$13,021$13,263$13,445
Total Curr. Assets$204,336$299,852$422,791$311,713
Property Plant & Equip (Net)$72,944$73,346$34,713$29,748
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$3,360$3,360$3,968$33,253
Tax Assets$0$0$0$5,180
Other NC Assets$92$94$803$696
Total NC Assets$76,396$76,800$39,484$68,877
Other Assets$0$0$0$0
Total Assets$280,732$376,652$462,275$380,590
Liabilities
Payables$1,948$8,002$4,097$6,000
Short-Term Debt$33,856$35,986$40,351$2,891
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,751$13,547$18,339$20,936
Total Curr. Liab.$48,555$57,535$62,787$29,827
LT Debt$167,200$190,072$182,090$23,795
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$5,180
Other NC Liab.$260$231$663$454
Total NC Liab.$167,460$190,303$182,753$29,429
Other Liabilities$0$0$0$0
Cap. Leases$54,757$55,467$26,513$22,372
Total Liabilities$216,015$247,838$245,540$59,256
Equity
Pref Stock$0$0$0$0
Common Stock$214$212$211$208
Retained Earnings-$404,929-$323,040-$206,995-$73,179
AOCI-$339$302-$1,174-$3,724
Other Equity$469,771$451,340$424,693$398,029
Total Equity$64,717$128,814$216,735$321,334
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$280,732$376,652$462,275$380,590
Net Debt$168,758$188,825$137,053-$17,308
Enanta Pharmaceuticals, Inc. (ENTA) Financial Statements & Key Stats | AlphaPilot